MedPharm Wins Category at 2019 CPhI Pharma Awards
The company announced it was named the winner of the Analysis, Testing, and Quality Control category.
MedPharm, a UK-based contract provider of topical and transdermal product design and formulation development services, announced it was named the winner of the Analysis, Testing, and Quality Control category at the 2019 CPhI Pharma Awards on Nov. 5, 2019.
According to a company press release, MedPharm attributes the win to its dedication to discovering new ways to demonstrate the bioequivalence of topical generic products in regulatory submissions. This includes working with regulatory authorities to develop in-vitro models and statistical justification using multiple donors.
“This award is a testament to MedPharm’s depth of experience and integrity in the field of in vitro modeling and topical formulation development,” said Eugene Ciolfi, president and CEO of MedPharm, in the press release. “By refining and automating these in-vitro models MedPharm has created a cost-effective route to demonstrating bioequivalence.”
Source: MedPharm
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
